Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices

Biological Psychiatry

Volumn 52, Issue 8, 2002, Pages 805-810

  Fatemi, S Hossein ^a   Halt, Amy R ^a   Stary, Joel M ^a   Kanodia, Reena ^a   Schulz, S Charles ^a   Realmuto, George R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Autism; Cerebellum; Gamma amino butyric acid; Glutamic acid decarboxylase; Parietal cortex; Schizophrenia; Western blotting

Indexed keywords

4 AMINOBUTYRIC ACID; AMOXAPINE; BETA ACTIN; BETHANECHOL; CARBAMAZEPINE; CEFADROXIL; CEFOPERAZONE; CLONAZEPAM; GABAPENTIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; IBUPROFEN; MESORIDAZINE BESYLATE; PHENOBARBITAL; PHENYTOIN; THEOPHYLLINE; THIORIDAZINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; AUTISM; BRAIN LEVEL; CADAVER; CAUSE OF DEATH; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR WEIGHT; PARIETAL LOBE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR DENSITY; SEIZURE; THROMBOCYTE; WESTERN BLOTTING;

ADULT; AUTISTIC DISORDER; BLOTTING, WESTERN; CEREBELLAR CORTEX; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MOLECULAR WEIGHT; PARIETAL LOBE;

EID: 0037108019     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01430-0     Document Type: Article

References (36)

1. Bauman M.L., Kemper T.L., The Neurobiology of Autism. 1994;19-145 Johns Hopkins University Press, Baltimore.
2. Belsito K., Law P.A., Kirk K.S., Landa R.J., Zimmerman A.W. Lamotrigine therapy for autistic disorder A randomized, double-blind, placebo-controlled trial . J Autism Dev Disord. 31:(2):2001;175-181.
3. Benes F.M., Berretta S. GABAergic interneurons Implications for understanding schizophrenia and bipolar disorder . Neuropsychopharmacology. 25:2001;1-27.
4. Courchesne E., Press G.A., Young-Courchesne R. Parietal lobe abnormalities detected with MR in patients with infantile autism. Am J Roentgenol. 160:1993;387-393.
5. Davanzo P.A., King B.H. Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. J Child Adolesc Psychopharmacol. 4:1996;273-279.
6. Erlander M.G., Tillakaratne N.J.K., Feldblum S., Patel N., Tobin A. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
7. Esclapez M., Tillakaratne N.J.K., Kaufman D.L., Tobin A.J., Horner C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci. 14:1994;1834-1855.
8. Fatemi S.H., Earle J., McMemony T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 5:2000;654-663.
9. Fatemi S.H., Halt A.R. Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse. 42:2001;281-284.
10. Fatemi S.H., Halt A.R., Earle J., Kist D.A., Realmuto G.R., Thuras P.D., Merz A. Reduced Purkinje cell size in autistic cerebellum. Biol Psychiatry. 47:2000;1285.
11. Fatemi S.H., Halt A.R., Realmuto G.M., Jalali-Mousavi M. Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum. Neuroreport. 12:2001;929-933.
12. Fatemi S.H., Kroll J., Stary J. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport. 12:2001;3209-3215.
13. Fatemi S.H., Stary J., Halt A.R., Realmuto G.R. Dysregulation of Reelin and Bc12 in autistic cerebellum. J Aut Dev Dis. 31:2001;529-535.
14. Feldblum S., Erlander M.G., Tobin A.J. Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J Neurosci Res. 34:1993;689-706.
15. Giorgi S., Rimoldi M., Rossi M., Consols S. The parafascicular thalamic nucleus modulates messenger RNA encoding glutamate decarboxylase 67 in rat striatum. Neuroscience. 80:1997;793-801.
16. Guidotti A., Auta J., Davis J.M., DiGiorgi-Garevini V., Dividedi Y., Grayson D., et al. Decrease in Reelin and glutamic acid decarboxylase 67 expression in schizophrenia and bipolar disorder A postmortem brain study . Arch Gen Psychiatry. 57:2000;1061-1069.
17. Haas R.H., Townsend J., Courchesne E., Lincoln A.J., Schreibman L., Young-Courchesne R. Neurologic abnormalities in infantile autism. J Child Neurol. 11:1996;84-92.
18. Izzo E., Auta J., Impagnatiello F., Pesold C., Guidotti A., Costa E. Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc Natl Acad Sci U S A. 98:2001;3483-3488.
19. King B.H., Wright D.M., Handen B.L., Sikich L., Zimmerman A.W., et al. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 40:2001;658-665.
20. Lacor P.N., Grayson D.R., Auta J., Sugaya I., Costa E., Guidotti A. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc Natl Acad Sci USA. 97:2000;3556-3561.
21. Laprade N., Soghomonian J.J. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differently altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse. 33:1999;36-48.
22. Liu W.S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lalor P., Larson J., et al. Downregulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haplo insufficient heterozygores reeler mouse. Proc Natl Acad Sci U S A. 98:2001;3477-3482.
23. Martin E.R., Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem. 60:1993;395-407.
24. Moreno H., Borjas L., Arrieta A., Salz L., Prassad A., Estevez J., et al. Clinical heterogeneity of the autistic syndrome A study of 60 families . Invest Clin. 33:1992;13-31.
25. Moreno-Fuenmayer H., Borjas L., Arrieta A., Valera V., Socorro-Candanoza L. Plasma excitatory amino acids in autism. Invest Clin. 37:1996;113-128.
26. Pan J.W., Lane J.B., Hetherington H., Percy A.K. Rett Syndrome H-1 spectroscopic imaging at + 1 Tesla . J Child Neurol. 14:1999;524-528.
27. Perry E.K., Lee M.L.W., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J., et al. Cholenergic activity in autism Abnormalities in the cerebral cortex and basal forebrain . Am J Psych. 158:2001;1058-1066.
28. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 57:2001;1618-1628.
29. Qin Z.-H., Zhang S.-P., Weiss B. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Brain Res Mol Brain Res. 21:1994;293-302.
30. Reetz A., Solimena M., Matteoli M., Folli F., Takei K., De Camilli P. Related Articles GABA and pancreatic beta-cells: Colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion . EMBO J. 10:1991;1275-1284.
31. Ritvo E.R., Freeman B.J., Scheibel A.B., Duong T., Robinson H., Guthrie D., Ritvo A. Lower Purkinje cell counts in the cerebella of four autistic subjects Initial findings of the UCLA-NSAC autopsy research report . Am J Psychiatry. 143:1986;862-866.
32. Rolf L.H., Haarmann F.Y., Grotemeyer K.H., Kehrer H. Serotonin and amino acid content in platelets of autistic children. Alta Psychiatr Scand. 87:1993;312-316.
33. Saitoh O., Courchesne E. Magnetic resonance imaging study of the brain in autism. Psychiatry Clin Neurosci. 52:1998;S219-222.
34. Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase Why? Trends Pharm Sci. 19:1998;500-505.
35. Townsend J., Harris N.S., Courchesne E. Visual attention abnormalities in autism Delayed orienting to location . J Int Neuropsychol Soc. 2:1996;541-550.
36. Uvebrant P., Bauziene R. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics. 6:1994;284-289.